Strategies for risk assessment in medication management: A systematic review of their impact on patient safety and operational efficiency
pdf (English)

Как цитировать

Rahmaddian, T., UKHTIL HUVAID, S., HIDAYAT , H., YULIANITA, Y. и OKTARINA, S. (2026) «Strategies for risk assessment in medication management: A systematic review of their impact on patient safety and operational efficiency», One Health & Risk Management , 7(2), сс. 4-17. doi: 10.38045/ohrm.2026.2.01.

Аннотация

Introduction.  Medication management is a complex, high-risk component of healthcare and remains vulnerable to errors that might affect patient safety and operational efficiency. This systematic review aimed to evaluate risk assessment strategies used in medication management and to synthesise evidence regarding their impact on patient safety and operational performance.
Materials and methods. A systematic review was conducted following PRISMA 2020 guidelines. Comprehensive searches of the Scopus and PubMed databases identified peer-reviewed studies published between 2020 and 2025. Using the PICOS framework, eligible studies evaluated risk assessment strategies within medication-use processes and reported patient-related safety and/or efficiency outcomes. Data were analysed through thematic synthesis.
Results. Sixteen studies met the inclusion criteria. Proactive risk assessment strategies - notably Failure Mode and Effects Analysis and its variants - were widely implemented across medication-use processes, particularly in high-risk settings. Their use improved the identification and prioritisation of medication-related risks, reduced error rates or risk scores, bolstered compliance with safety protocols, and optimised workflow organisation and resource allocation. Technology-driven tools further enhanced effectiveness by enabling standardisation and continuous monitoring.
Conclusions. Structured risk assessment strategies measurably improve patient safety and operational efficiency in medication management. Further longitudinal and comparative research is required to evaluate long-term clinical and economic outcomes.

https://doi.org/10.38045/ohrm.2026.2.01
pdf (English)

|Просмотры: 527| |pdf (English) Скачивания: 183|


pdf (English)
Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.

Copyright (c) 2026 Tosi Rahmaddian, Sevilla Ukhtil Huvaid Ukhtil Huvaid, Hilda Hidayat , Yulianita Yulianita, Sri Oktarina

Скачивания

Данные скачивания пока недоступны.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370